Abstract

? HIV CURE SWG The HIV Cure Scientific Working Group is designed to provide a platform for generating new research in the area of HIV cure and also to create an environment to mentor and support young investigators. UNC has become an important center of cure research, hosting one of the Delaney Collaboratories, a multi-institution effort that includes Merck Pharmaceutical investigators. In addition the HIV Cure Center was recently formed as a private-public partnership with GSK. UNC also has significant strengths drug discovery, pharmacology, the regulation of chromatin modification, and expanding expertise in HIV immunology looking ahead to therapeutic vaccinations. The first goal of the HIV Cure SWG is to bring together this diverse set of investigators, including collaborators at other CFARs through video conferencing and from industry, to share data and explore ideas for new research pathways. The second goal of the HIV Cure SWG is to mentor and support new investigators on their path to independence. Taken together these two goals will advance cure research in the present and prepare the next generation of cure researchers for their own successes in the future. The HIV Cure SWG will be led by Dr. David Margolis, who also leads the Delaney Care Collaboratory and the HIV Cure Center, and by Dr. Andrew Spaltenstein, who is Vice President of the HIV Discovery Performance Unit of GSK and a new member of the HIV Cure Center.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI050410-23
Application #
9990651
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2001-08-20
Project End
2021-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
23
Fiscal Year
2020
Total Cost
Indirect Cost

  Institution

Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599

  Publications

Tang, Jennifer H; Lemani, Clara; Nkambule, Jerome et al. (2018) Two-year contraceptive continuation rates among immediate postpartum implant users at a district hospital in Malawi: a prospective cohort study. Contraception 98:220-222
Zule, William A; Latypov, Alisher; Otiashvili, David et al. (2018) Feasibility of needle and syringe programs in Tajikistan distributing low dead space needles. Harm Reduct J 15:44
Chi, Benjamin H; Rosenberg, Nora E; Mweemba, Oliver et al. (2018) Involving both parents in HIV prevention during pregnancy and breastfeeding. Bull World Health Organ 96:69-71
Costenbader, Elizabeth; Mangone, Emily; Mueller, Monique et al. (2018) Rapid organizational network analysis to assess coordination of services for HIV testing clients: an exploratory study. J HIV AIDS Soc Serv 17:16-31
Srinivas, Nithya; Maffuid, Kaitlyn; Kashuba, Angela D M (2018) Clinical Pharmacokinetics and Pharmacodynamics of Drugs in the Central Nervous System. Clin Pharmacokinet 57:1059-1074
Mbichila, Tinkhani H; Chagomerana, Maganizo; Tang, Jennifer H et al. (2018) Partnership duration and HIV serodisclosure among people living with HIV/AIDS in Lilongwe, Malawi. Int J STD AIDS 29:987-993
Rosenberg, Nora E; Graybill, Lauren A; Wesevich, Austin et al. (2018) Individual, Partner, and Couple Predictors of HIV Infection among Pregnant Women in Malawi: A Case-Control Study. AIDS Behav 22:1775-1786
Li, Binglan; Verma, Shefali S; Veturi, Yogasudha C et al. (2018) Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression. Pac Symp Biocomput 23:448-459
Ong, Jason J; Fu, Hongyun; Smith, M Kumi et al. (2018) Expanding syphilis testing: a scoping review of syphilis testing interventions among key populations. Expert Rev Anti Infect Ther 16:423-432
Wu, Feng; Zhang, Alice; Babbitt, Andrew et al. (2018) Overcoming HIV Stigma? A Qualitative Analysis of HIV Cure Research and Stigma Among Men Who Have Sex with Men Living with HIV. Arch Sex Behav 47:2061-2069

Showing the most recent 10 out of 1688 publications